
The past few years have seen dramatic advances in the treatment of zzso zzso cell zzso zzso zzso of the molecular pathways that regulate zzso zzso and zzso has led to the development of targeted therapies such as the zzso zzso zzso zzso zzso and zzso the zzso zzso growth factor zzso zzso and a class of zzso zzso including zzso and zzso Each of these agents has demonstrated clinical efficacy in patients with zzso zzso The challenge before us is to expand on these successes by identifying which patients will best respond to these targeted therapies, zzso the proper combination or sequence of available therapies, developing agents with improved side effect profiles, and identifying novel therapeutic targets to expand our zzso in the treatment of zzso 

